The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The angiotensin II type 2 receptor agonist Compound 21 is protective in experimental diabetes-associated atherosclerosis
Authors
Keywords
Angiotensin II, AT<sub>2</sub> receptor, Atherosclerosis, Compound 21, Diabetes
Journal
DIABETOLOGIA
Volume 59, Issue 8, Pages 1778-1790
Publisher
Springer Nature
Online
2016-05-11
DOI
10.1007/s00125-016-3977-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of the Vasoconstriction-Inhibiting Factor (VIF), a Potent Endogenous Cofactor of Angiotensin II Acting on the Angiotensin II Type 2 Receptor
- (2015) S. Salem et al. CIRCULATION
- AT2R Agonist, Compound 21, Is Reno-Protective Against Type 1 Diabetic Nephropathy
- (2015) C. Koulis et al. HYPERTENSION
- A Nonpeptide Angiotensin II Type 2 Receptor Agonist Prevents Renal Inflammation in Early Diabetes
- (2015) Luis C. Matavelli et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Recent insights into the cellular biology of atherosclerosis
- (2015) Ira Tabas et al. JOURNAL OF CELL BIOLOGY
- Relative affinity of angiotensin peptides and novel ligands at AT1and AT2receptors
- (2015) Sanja Bosnyak et al. CLINICAL SCIENCE
- Role of bone-marrow- and non-bone-marrow-derived receptor for advanced glycation end-products (RAGE) in a mouse model of diabetes-associated atherosclerosis
- (2014) Christine Koulis et al. CLINICAL SCIENCE
- Bone marrow angiotensin AT2 receptor deficiency aggravates atherosclerosis development by eliminating macrophage liver X receptor-mediated anti-atherogenic actions
- (2014) Taku Kato et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis
- (2014) Bryna S. Man Chow et al. KIDNEY INTERNATIONAL
- AT1 receptor blocker potentiates shear-stress induced nitric oxide production via modulation of eNOS phosphorylation of residues Thr495 and Ser1177
- (2013) Valério G. Barauna et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Proximal Tubule Angiotensin AT 2 Receptors Mediate an Anti-Inflammatory Response via Interleukin-10
- (2013) Isha Dhande et al. HYPERTENSION
- Direct AT2 receptor stimulation is athero-protective and stabilizes plaque in Apolipoprotein E-deficient mice
- (2013) Sonja Tesanovic Kljajic et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- The Role of Monocytes in Angiogenesis and Atherosclerosis
- (2013) Anthony S. Jaipersad et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Vascular angiotensin II type 2 receptor attenuates atherosclerosis via a kinin/NO-dependent mechanism
- (2013) Hiroki Takata et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- PD123319 Augments Angiotensin II-Induced Abdominal Aortic Aneurysms through an AT2 Receptor-Independent Mechanism
- (2013) Alan Daugherty et al. PLoS One
- Heteromerization of angiotensin receptors changes trafficking and arrestin recruitment profiles
- (2011) Enzo R. Porrello et al. CELLULAR SIGNALLING
- Angiotensin II Type II Receptor Deficiency Accelerates the Development of Nephropathy in Type I Diabetes via Oxidative Stress and ACE2
- (2011) Shiao-Ying Chang et al. Experimental Diabetes Research
- Angiotensin Type 2 Receptor Agonist Compound 21 Reduces Vascular Injury and Myocardial Fibrosis in Stroke-Prone Spontaneously Hypertensive Rats
- (2011) Asia Rehman et al. HYPERTENSION
- Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status
- (2010) Terry KW Ma et al. BRITISH JOURNAL OF PHARMACOLOGY
- Stimulation of angiotensin AT2 receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats
- (2010) S Bosnyak et al. BRITISH JOURNAL OF PHARMACOLOGY
- Angiotensin AT 2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension
- (2010) Luis C. Matavelli et al. HYPERTENSION
- Effects of Angiotensin Type I Receptor Blockade on the Cardiac Raf/MEK/ERK Cascade Activated via Adrenergic Receptors
- (2010) Guo-Xing Zhang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes
- (2009) A. Koïtka et al. DIABETOLOGIA
- Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis
- (2008) Barbara Ulmasov et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Angiotensin II Type 2 Receptor Stimulation
- (2008) Elena Kaschina et al. CIRCULATION
- Angiotensin type 2 receptor is expressed in human atherosclerotic lesions
- (2008) Maria E Johansson et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- Over-expression of angiotensin II type 2 receptor (agtr2) reduces atherogenesis and modulates LOX-1, endothelial nitric oxide synthase and heme-oxygenase-1 expression
- (2007) Changping Hu et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now